Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management
出版年份 2021 全文链接
标题
Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management
作者
关键词
-
出版物
AMERICAN JOURNAL OF HEMATOLOGY
Volume 96, Issue 4, Pages 508-525
出版商
Wiley
发表日期
2021-02-03
DOI
10.1002/ajh.26118
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Features and Survival of Patients with Indolent Systemic Mastocytosis defined by the Updated WHO Classification
- (2020) Jakub Trizuljak et al. ALLERGY
- Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
- (2020) Georg Greiner et al. BLOOD
- World Health Organization class-independent risk categorization in mastocytosis
- (2019) Animesh Pardanani et al. Blood Cancer Journal
- MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis
- (2019) Mohamad Jawhar et al. JOURNAL OF CLINICAL ONCOLOGY
- International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
- (2019) Wolfgang R Sperr et al. Lancet Haematology
- Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial
- (2018) Bjorn van Anrooij et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis
- (2018) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial
- (2017) D J DeAngelo et al. LEUKEMIA
- A precision therapy against cancers driven by KIT/PDGFRA mutations
- (2017) Erica K. Evans et al. Science Translational Medicine
- Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival
- (2016) Animesh Pardanani et al. AMERICAN JOURNAL OF HEMATOLOGY
- Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis
- (2016) Celalettin Ustun et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Resolution of osteosclerosis after alloHCT in systemic mastocytosis
- (2016) C. Ustun et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis
- (2016) M Jawhar et al. LEUKEMIA
- Midostaurin in Advanced Systemic Mastocytosis
- (2016) Marie-Olivia Chandesris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
- (2016) Jason Gotlib et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis
- (2015) S. Barete et al. BLOOD
- Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis
- (2015) M Jawhar et al. LEUKEMIA
- Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
- (2014) Celalettin Ustun et al. JOURNAL OF CLINICAL ONCOLOGY
- International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis
- (2013) J. Gotlib et al. BLOOD
- CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis
- (2013) José M Morgado et al. HISTOPATHOLOGY
- Increased circulating IL-2Rα (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine–phenotype study
- (2013) A Pardanani et al. LEUKEMIA
- In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells
- (2012) E. Soucie et al. BLOOD
- Immunophenotyping in systemic mastocytosis diagnosis: ‘CD25 positive’ alone is more informative than the ‘CD25 and/or CD2’ WHO criterion
- (2012) José Mário T Morgado et al. MODERN PATHOLOGY
- Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
- (2011) Peter Valent et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis
- (2011) C Teodosio et al. LEUKEMIA
- Evaluation of the WHO criteria for the classification of patients with mastocytosis
- (2011) Laura Sánchez-Muñoz et al. MODERN PATHOLOGY
- WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults
- (2010) A. Pardanani et al. BLOOD
- Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit
- (2010) A. Gerbaulet et al. BLOOD
- In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
- (2010) Alexandra Böhm et al. EXPERIMENTAL HEMATOLOGY
- Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes
- (2010) Cristina Teodosio et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis
- (2010) Karl Sotlar et al. MODERN PATHOLOGY
- Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine
- (2009) Ken H. Lim et al. AMERICAN JOURNAL OF HEMATOLOGY
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
- (2009) K.-H. Lim et al. BLOOD
- Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
- (2009) A. Pardanani et al. BLOOD
- Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology
- (2009) W. R. Sperr et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients
- (2009) Luis Escribano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
- (2009) Christine Bodemer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Variable presence ofKITD816Vin clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)
- (2009) Karl Sotlar et al. JOURNAL OF PATHOLOGY
- Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
- (2009) A Tefferi et al. LEUKEMIA
- Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis
- (2009) Arturo Vega-Ruiz et al. LEUKEMIA RESEARCH
- Pediatric-onset mastocytosis: A long term clinical follow-up and correlation with bone marrow histopathology
- (2009) Ashraf Uzzaman et al. PEDIATRIC BLOOD & CANCER
- Advanced mast cell disease: an Italian Hematological Multicenter experience
- (2008) Livio Pagano et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started